These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 30793770

  • 1. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
    Ma J, Huang X, Li Z, Shen Y, Lai J, Su Q, Zhao J, Xu J.
    J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
    [Abstract] [Full Text] [Related]

  • 2. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
    Zhang X, Li M, Zuo K, Li D, Ye M, Ding L, Cai H, Fu D, Fan Y, Lv Z.
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
    [Abstract] [Full Text] [Related]

  • 3. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S, Qu W, Jiao Y, Zhang J, Zhang C, Dang S.
    Cancer Biomark; 2018 Aug; 22(2):217-226. PubMed ID: 29630517
    [Abstract] [Full Text] [Related]

  • 4. FOXE1 inhibits cell proliferation, migration and invasion of papillary thyroid cancer by regulating PDGFA.
    Ding Z, Ke R, Zhang Y, Fan Y, Fan J.
    Mol Cell Endocrinol; 2019 Aug 01; 493():110420. PubMed ID: 31129275
    [Abstract] [Full Text] [Related]

  • 5. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
    Zhou Z, Liu Y, Ma M, Chang L.
    Biomed Pharmacother; 2017 Dec 01; 96():98-103. PubMed ID: 28965013
    [Abstract] [Full Text] [Related]

  • 6. FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway.
    Zhao C, Mo L, Li C, Han S, Zhao W, Liu L.
    Mol Cell Endocrinol; 2020 Sep 15; 515():110925. PubMed ID: 32619584
    [Abstract] [Full Text] [Related]

  • 7. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.
    Geng Q, Deng H, Fu J, Cui F.
    Exp Cell Res; 2020 Nov 01; 396(1):112249. PubMed ID: 32858034
    [Abstract] [Full Text] [Related]

  • 8. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway.
    Bi W, Huang J, Nie C, Liu B, He G, Han J, Pang R, Ding Z, Xu J, Zhang J.
    J Exp Clin Cancer Res; 2018 Nov 13; 37(1):275. PubMed ID: 30424816
    [Abstract] [Full Text] [Related]

  • 9. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.
    Wang X, Lu X, Geng Z, Yang G, Shi Y.
    J Cell Biochem; 2017 Dec 13; 118(12):4745-4752. PubMed ID: 28513866
    [Abstract] [Full Text] [Related]

  • 10. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway.
    Zhong J, Lin R, Wang G, Lin L, Ruan S, Liu W.
    Tissue Cell; 2022 Apr 13; 75():101739. PubMed ID: 35066335
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signaling.
    Cho SW, Kim YA, Sun HJ, Ahn HY, Lee EK, Yi KH, Oh BC, Park DJ, Cho BY, Park YJ.
    J Clin Endocrinol Metab; 2014 Sep 13; 99(9):E1641-9. PubMed ID: 24848709
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
    Wen D, Liao T, Ma B, Qu N, Shi RL, Lu ZW, Wang YL, Wei WJ, Ji QH.
    Cancer Med; 2018 Feb 13; 7(2):285-296. PubMed ID: 29341469
    [Abstract] [Full Text] [Related]

  • 13. Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling Pathway.
    Yang M, Huang S, Zhao Y, Xie B, Hu X, Cai Y.
    Biochem Biophys Res Commun; 2023 May 07; 655():104-109. PubMed ID: 36934585
    [Abstract] [Full Text] [Related]

  • 14. SDC4 Gene Silencing Favors Human Papillary Thyroid Carcinoma Cell Apoptosis and Inhibits Epithelial Mesenchymal Transition via Wnt/β-Catenin Pathway.
    Chen LL, Gao GX, Shen FX, Chen X, Gong XH, Wu WJ.
    Mol Cells; 2018 Sep 30; 41(9):853-867. PubMed ID: 30165731
    [Abstract] [Full Text] [Related]

  • 15. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
    Michelotti G, Jiang X, Sosa JA, Diehl AM, Henderson BB.
    Oncotarget; 2015 Oct 27; 6(33):34549-60. PubMed ID: 26416247
    [Abstract] [Full Text] [Related]

  • 16. CDK5RAP3 acts as a putative tumor inhibitor in papillary thyroid carcinoma via modulation of Akt/GSK-3β/Wnt/β-catenin signaling.
    Feng X, Jiang J, Sun L, Zhou Q.
    Toxicol Appl Pharmacol; 2022 Apr 01; 440():115940. PubMed ID: 35219640
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
    Li JY, Han C, Zheng LL, Guo MZ.
    Chin Med J (Engl); 2012 Oct 01; 125(19):3526-31. PubMed ID: 23044318
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of FHL1 suppresses papillary thyroid cancer proliferation and progression via inhibiting Wnt/β-catenin pathway.
    Chen J, Zeng C, Jin J, Zhang P, Zhang Y, Zhang H, Li Y, Guan H.
    Endocrine; 2024 Jul 01; 85(1):238-249. PubMed ID: 38191984
    [Abstract] [Full Text] [Related]

  • 19. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.
    Qiu W, Yang Z, Fan Y, Zheng Q.
    Tumour Biol; 2016 Sep 01; 37(9):12665-12672. PubMed ID: 27448298
    [Abstract] [Full Text] [Related]

  • 20. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway.
    Xiao X, Li L, Cui JC, Wang Y.
    Eur Rev Med Pharmacol Sci; 2020 Apr 01; 24(8):4361-4367. PubMed ID: 32373973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.